This site is intended for UK healthcare professionals
Medscape UK Univadis Logo
Medscape UK Univadis Logo
More from medscape

News

Having Flu and COVID Vaccines at Same Time Is Safe: ComFluCOV Study

Having flu and COVID jabs at the same time is safe, according to preprint research from the ComFluCOV study.

The University Hospitals Bristol and Weston NHS Foundation Trust-led study supports giving COVID booster doses alongside the seasonal flu programme.

Researchers concluded that concomitant vaccination did not raise safety concerns, and the immune response to both vaccines was preserved.

Side effects were reported for some combinations but were found to be mainly mild to moderate, including fatigue, apart from one hospitalisation with severe headache related to the trial.

Study Details

The trial involved 679 participants across 12 sites. They'd had a first dose of Oxford/AstraZeneca or Pfizer/BioNTech COVID vaccines.

When they had their second dose, they were randomised to also receive one of three different flu jabs or placebo in the other arm (or thigh in some cases).

Three weeks later the initial placebo group had a flu jab, and the flu jabs groups had a placebo.

Side effects were reported for the six possible combinations through electronic diaries.

The authors concluded: "Concomitant vaccination with both COVID-19 and influenza vaccines over the next immunisation season should reduce the burden on the healthcare services for vaccine delivery, allowing for timely vaccine administration and protection from COVID-19 and influenza for those in need."

Wise and Precautionary Checks

Commenting via the Science Media Centre, Dr Peter English, retired consultant in communicable disease control, said: "We would not expect any problems to arise from coadministration of flu and COVID-19 vaccines; but it is wise and precautionary to check for possible problems in clinical trials before authorising or recommending widespread coadministration. This study does just that."

The study received Department of Health and Social Care and National Institute for Health Research funding.

Another commenter, Professor Penny Ward, independent pharmaceutical physician, visiting professor in pharmaceutical medicine, King's College London, said the study helped to answer a question she'd been asking herself.

"It's not often that a publication is directly relevant to one's own health decision making. Being a lady of mature years, I have just received my invitation for the annual influenza vaccination, but the set date is a month or so prior to the earliest date I would be called for a COVID vaccine booster. What to do – wait and have them both together or take one then t'other?"

She continued: "I think I can be confident that I can go ahead with my flu shot while waiting to be called up for the COVID vaccine booster. Thanks to the ComCov study team for getting this out into the public domain so I could answer my own question without needing to bother the local GP. Let's get this out on the airwaves so other members of the public with the same dilemma can be similarly reassured."

‘The safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults: a phase IV, multicentre randomised controlled trial with blinding (ComFluCOV)' preprint by Rajeka Lazarus et al.

Register Today

Already a member? Log in

YOU MAY ALSO LIKE

NICE recommended monthly injections of eplontersen at home for adults with hereditary transthyretin-mediated amyloidosis and stage 1 or stage 2 polyneuropathy.
MPs vote tomorrow whether a bill to legalise assisted dying in the UK should progress through parliament.
Menopause before age 40 years increased the risk by nearly 50% when compared with menopause in the average age range.
The Swiss HIV National Cohort findings challenged guidelines on low-level viremia.
A randomised phase 3 trial in patients with low-risk differentiated thyroid cancer showed no outcome difference at 5 years.
It comes as figures showed there were now more doctors from an ethnic minority background on the register than white doctors.
While tapering corticosteroids can reduce infections and hospitalizations for patients with severe alcohol-associated hepatitis, it may not affect survival outcomes.
The former head of a French hospital's emergency department explained why patients were transferred to a nearby garage during times of overcrowding.
A clinical trial examined benralizumab, a monoclonal antibody that targets eosinophils to reduce lung inflammation.
Of 3000 men who visited at various London sites, 16% of attendees and 22% of those diagnosed with prostate cancer were Black.
Covers NICE, BTS, and SIGN’s joint recommendations on diagnosing, monitoring, and managing asthma in adults, young people, and children
The addition of prolonged grief disorder to the DSM-5-TR in 2022 as a new psychiatric illness was met with some resistance. Two years later, the debate continued.
The risk was more than doubled for infants initially discharged home in fall or winter.
Analysis of randomised clinical trial data suggested that a single-dose 3,4-methylenedioxymethamphetamine can cause acute hyponatremia in about a third of healthy young people.
The online intervention, now being implemented globally, failed to reduce distress or depression at 6 months.
Observational studies suggest that multiple dietary approaches can help stem progression.
Earlier this year, researchers reported the first known evidence of microplastics in the human brain. But what does it mean?
Dr Jason Yeung and Dr Steve Bandula discuss the role of interventional oncology procedures in cancer management to enhance oncology practice and improve patient outcomes
A collection of common and new medications is showing good results against the constellation of symptoms that individualize long COVID. Here’s the latest.